Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - INTEREST INCOME & EXPENSE
Interest Income & Expense SMMT - Summit Therapeutics Inc.
16.5 M
LAST VALUE
665.38%
2 YEAR CAGR
96.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR